State Of Wyoming Biocryst Pharmaceuticals Inc Transaction History
State Of Wyoming
- $754 Million
- Q4 2024
A detailed history of State Of Wyoming transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, State Of Wyoming holds 42,303 shares of BCRX stock, worth $350,268. This represents 0.04% of its overall portfolio holdings.
Number of Shares
42,303
Previous 52,517
19.45%
Holding current value
$350,268
Previous $399,000
20.3%
% of portfolio
0.04%
Previous 0.06%
Shares
15 transactions
Others Institutions Holding BCRX
# of Institutions
278Shares Held
167MCall Options Held
728KPut Options Held
989K-
Vanguard Group Inc Valley Forge, PA21.9MShares$181 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$165 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$98.2 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$75.2 Million4.33% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$67.4 Million1.52% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.54B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...